Robert W. Baird Issues Pessimistic Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG) had its price objective trimmed by Robert W. Baird from $600.00 to $575.00 in a report published on Wednesday,Benzinga reports. The brokerage currently has an outperform rating on the medical equipment provider’s stock.

ISRG has been the topic of several other research reports. Barclays raised their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Royal Bank of Canada raised their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Jefferies Financial Group lifted their target price on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Citigroup increased their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Finally, Evercore ISI lifted their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $598.95.

Intuitive Surgical Stock Up 1.3 %

NASDAQ ISRG opened at $514.59 on Wednesday. Intuitive Surgical has a 52 week low of $367.39 and a 52 week high of $616.00. The business has a 50 day moving average price of $511.92 and a 200-day moving average price of $532.42. The company has a market cap of $183.29 billion, a price-to-earnings ratio of 80.28, a P/E/G ratio of 5.85 and a beta of 1.55.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the business posted $1.50 EPS. On average, equities research analysts anticipate that Intuitive Surgical will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Gary Loeb sold 1,700 shares of Intuitive Surgical stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the transaction, the executive vice president now owns 2,245 shares of the company’s stock, valued at approximately $1,152,089.10. This trade represents a 43.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 35,454 shares of company stock worth $18,564,027. Company insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors and hedge funds have recently modified their holdings of ISRG. Atala Financial Inc bought a new position in Intuitive Surgical in the 4th quarter valued at $25,000. Hurley Capital LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth $28,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth $26,000. Parvin Asset Management LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at $26,000. Finally, BankPlus Trust Department purchased a new position in Intuitive Surgical during the fourth quarter worth about $28,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.